Lupin reported INR74.75B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Bharat Petroleum INR 1.51T 270B Jun/2026
Cipla INR 71.19B 5.78B Jun/2026
Divis Laboratories Ltd INR 28.31B 2.27B Mar/2026
Dr.Reddys Laboratories INR 80.71B 5.25B Jun/2026
Sun Pharmaceuticals INR 145.86B 2.13B Mar/2026
UPL INR 183.35B 59.74B Mar/2026